GotchFSargentJA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int1985; 28: 526–534.
3.
von AlbertiniBMillerJGardenerPet al. High-flux hemodiafiltration: under six hours /week Rx. Trans Am Soc Artif Intern Organs1984; 30: 227–231.
4.
MillerJvon AlbertiniBGardnerPet al. Technical aspects of high-flux hemodiafiltration for adequate short (under 2 hours) treatment. Trans Am Soc Artif Intern Organs1984; 30: 377–381.
5.
von AlbertiniBMillerJGardnerPet al. Performance characteristics of high flux hemodiafiltration. Proc Eur Dial Transplant Assoc1984; 21: 447–453.
WizemannVKramerW. Short time dialysis—long term complications. Ten years’ experience with sort-duration renal replacement therapy. Blood Purif1987; 5: 193–201.
8.
GurlandHJMujaisS.Treacherous fantasy: the unfullfilled promise of Kt/V. In: FriedmanEA (ed.) Death on Hemodialysis, Preventable or Inevitable. Boston, London: Kluwer Academic Publishers, 1994, pp. 35–43.
9.
PernodGBossonJLGolshayanDet al. The Diamant Alpin Dialysis Cohort Study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients. J Nephrol2004; 17: 66–75.
10.
MessaPMacárioFYaqoobMet al. The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism. Clin J Am Soc Nephrol2008; 3: 36–45.
11.
CanaudBet al. Intravenous C.E.R.A maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study. Nephrol Dial Transplant2008; 23: 3654–3661.
12.
WalpothBvon AlbertiniB. Ultrafiltration in cardiac surgery. J Extra Corpor Technol1984; 16(2): 68–72.